AYTU BIOPHARMA, INC Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
AYTU BIOPHARMA, INC (AYTU) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $8.00 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2023-10-12.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2023-10-12
- AYTU BIOPHARMA, INC share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-06-30 was $0.00.
- AYTU BIOPHARMA, INC share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-03-31 was $2.00K.
- AYTU BIOPHARMA, INC share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2021-09-30 was $6.00K.
- AYTU BIOPHARMA, INC share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $8.00K, a 60.00% increase from fiscal 2021.
- AYTU BIOPHARMA, INC share-based payment arrangement, decrease for tax withholding obligation for fiscal 2021 was $5.00K.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $2.00K derived: sum of 2 quarters · filed 2023-10-12 | $8.00K 10-K · filed 2023-10-12 | |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-11 | $8.00K 10-Q · filed 2022-05-16 | ||
| 2021-09-30 | $6.00K 10-Q · filed 2023-05-11 | |||
| 2021-06-30 | $5.00K 10-K · filed 2022-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |